Navigation Links
Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
Date:8/19/2007

bal development and commercialization agreement.

For additional information on Kosan Biosciences, please visit the Company's website at http://www.kosan.com.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 (the "Act"). Such forward-looking statements include but are not limited to statements related to the further development and potential safety, efficacy, commercialization and other characteristics of tanespimycin or tanespimycin injectable suspension, Kosan's development plans with respect to tanespimycin, including but not limited to Kosan's plans and timing for the initiation of TIME-2, TIME-2 as a potential registration trial, and potential accelerated registration strategy for tanespimycin. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. There are a number of important factors that could cause the results of Kosan to differ materially from those indicated by these forward-looking statements, including, among others, risks related to the development of tanespimycin, including the risk that studies may not demonstrate safety and efficacy sufficient to initiate additional clinical trials, continue clinical development on the timing currently anticipated or at all, obtain the requisite regulatory approvals or result in a marketable product; and other risks detailed from time to time in the Kosan's SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 and other periodic filings with the SEC. Kosan does not undertake any obligation to update forward-looking statements.

Velcade(R) (bortezomib) is a registered trademark of Millennium

Pharmaceuticals, Inc.

Herceptin(R) (trastuzumab) is a registered trademark of Genentech, Inc.

Revlimid(R) (lena
'/>"/>

SOURCE Kosan Biosciences Incorporated

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
6. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
7. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
8. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
9. Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
10. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
11. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7, 2015   Bionik Laboratories Corp. ... with a core focus in robotic exoskeleton technology ... "Company"), announced today that it has completed an ... consisting of its common stock and warrants for ... a private placement transaction.  This equity financing is ...
(Date:7/7/2015)... Oasmia Pharmaceutical AB, a ... human and veterinary oncology, today announced that it ... the United States , designed to generate ... therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... Paccal Vet-CA1 was previously distributed by ...
(Date:7/7/2015)...  Monopar Therapeutics LLC, an emerging biopharmaceutical company focusing ... and CEO, Chandler D. Robinson MD, MBA, ... Award. The British Council selected one recipient from each ... , and the United States ... who have leveraged their U.K. education in their subsequent ...
Breaking Medicine Technology:Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... pharmaceutical and medical device companies evolve, market research ... refining current ones to support intelligent planning and ... beginning to explore different types of technological advances ... external data collection and internal asset creation. ...
... 2012   CareFusion Corp. (NYSE: CFN ... that its board of directors authorized the repurchase of ... (Logo:  http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO ) "This ... potential and our commitment to increasing shareholder value," said ...
Cached Medicine Technology:Pharmaceutical Industry Leveraging New Tools to Overcome Challenges in Market Research 2CareFusion Announces $500 Million Share Repurchase Program 2CareFusion Announces $500 Million Share Repurchase Program 3
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern ... pass those long, stressful days at work is knowing that there is hopefully a ... back and stress free as imagined. Planning for a vacation can be quite stressful, ...
(Date:7/7/2015)... ... , ... The United States Centers for Disease Control and Prevention have awarded ... Multicultural AIDS Coalition $3.78 million for a five-year HIV prevention partnership that will ... transgender women, the groups at highest risk of HIV infection in the US. ...
(Date:7/7/2015)... MD (PRWEB) , ... July 07, 2015 , ... SC&H ... of Service, which aims to give back to the community through company-wide volunteering efforts. ... from SC&H Group dedicate the day to assisting those in need throughout Baltimore and ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation ... patient community using its IDF ePHR, an electronic personal health record powered by ... to easily track their health information, including symptoms, diagnoses, medications, infusions and other ...
(Date:7/7/2015)... ... July 07, 2015 , ... FSAstore.com today announced the launch ... holders. HSAstore.com makes it simple to use, spend and manage HSA funds with innovative ... accounts. , According to a report by Devenir , approximately 13.8 million ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3
... stem cells, which may provide a treatment for tumors ... pancreatic cancer, according to new research from Memorial Sloan-Kettering ... important since pancreatic cancer has a poor prognosis and ... Investigators led by Joyce Wong, MD, surgical researcher ...
... , NEW YORK (May 6, 2011) -- Among ... meeting are physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical ... McCormick Place, Chicago. The following are two notable ... A gastroenterologist at NewYork-Presbyterian Hospital/Columbia University Medical Center ...
... gene expression of their lungs similar to that suffered by ... is the conclusion of a new study, led by Catalan ... causing these alterations. "Our objective was to analyse the ... samples of patients with COPD, whether smokers or not, and ...
... up to a year before a patient is diagnosed with ... often mistaken for other diseases. However, with this blood-based test, ... disease or not", says Christer Wingren, associate professor in Immunotechnology ... determine how far the disease has progressed. There are three ...
... post-mortem tissue archive for a study of the human form ... by coroners to participate. The Coroners, Society of England and ... public health" from potential new risks associated with variant Creutzfeldt-Jakob ... of tissue from autopsies. That is the conclusion of a ...
... (HealthDay News) -- Children conceived in winter seem to have ... study suggests. Environmental factors -- including exposure to seasonal ... play a role in the greater risk for autism among ... California, Davis researchers. The investigators analyzed data from 6.6 ...
Cached Medicine News:Health News:Oncolytic viruses effectively target and kill pancreatic cancer stem cells 2Health News:NY Presbyterian/Columbia research presented at Digestive Disease Week meeting 2Health News:Smokers undergo the same changes in gene expression as patients with COPD 2Health News:New test could give SLE patients a more tolerable life 2Health News:Coroners wrong to say no to post-mortem tissue collection, academics argue 2Health News:Winter Conception Tied to Raised Risk for Autism 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: